The global biopharmaceutical third party logistics market size is calculated at USD 152.89 billion in 2025 and is forecasted to reach around USD 271.76 billion by 2034, accelerating at a CAGR of 6.60% from 2025 to 2034. The North America market size surpassed USD 61.00 billion in 2024 and is expanding at a CAGR of 6.62% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
Biopharmaceutical Third Party Logistics Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biopharmaceutical Third Party Logistics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biopharmaceutical Third Party Logistics Market, by Service Type
8.1.1. Transportation
8.1.1.1. Market Revenue and Forecast
8.1.2. Packaging Services
8.1.2.1. Market Revenue and Forecast
8.1.3. Value-Added Services
8.1.3.1. Market Revenue and Forecast
9.1. Biopharmaceutical Third Party Logistics Market, by Product Type
9.1.1. Biologics
9.1.1.1. Market Revenue and Forecast
9.1.2. Biosimilars
9.1.2.1. Market Revenue and Forecast
9.1.3. Small Molecule Drugs
9.1.3.1. Market Revenue and Forecast
9.1.4. Personalized Medicine
9.1.4.1. Market Revenue and Forecast
9.1.5. Clinical Trial Materials
9.1.5.1. Market Revenue and Forecast
10.1. Biopharmaceutical Third Party Logistics Market, by Mode of Transportation
10.1.1. Air Freight
10.1.1.1. Market Revenue and Forecast
10.1.2. Ocean Freight
10.1.2.1. Market Revenue and Forecast
10.1.3. Rail Freight
10.1.3.1. Market Revenue and Forecast
10.1.4. Road Freight
10.1.4.1. Market Revenue and Forecast
11.1. Biopharmaceutical Third Party Logistics Market, by End User
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceutical and BioService Type
11.1.2.1. Biotechnology Companies
11.1.3. Hospitals and Clinics
11.1.3.1. Market Revenue and Forecast
11.1.4. Research Organizations
11.1.4.1. Market Revenue and Forecast
11.1.5. Pharmacies and Distributors
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Service Type
12.1.2. Market Revenue and Forecast, by Product Type
12.1.3. Market Revenue and Forecast, by Mode of Transportation
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Service Type
12.1.5.2. Market Revenue and Forecast, by Product Type
12.1.5.3. Market Revenue and Forecast, by Mode of Transportation
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Service Type
12.1.6.2. Market Revenue and Forecast, by Product Type
12.1.6.3. Market Revenue and Forecast, by Mode of Transportation
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Service Type
12.2.2. Market Revenue and Forecast, by Product Type
12.2.3. Market Revenue and Forecast, by Mode of Transportation
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Service Type
12.2.5.2. Market Revenue and Forecast, by Product Type
12.2.5.3. Market Revenue and Forecast, by Mode of Transportation
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Service Type
12.2.6.2. Market Revenue and Forecast, by Product Type
12.2.6.3. Market Revenue and Forecast, by Mode of Transportation
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Service Type
12.2.7.2. Market Revenue and Forecast, by Product Type
12.2.7.3. Market Revenue and Forecast, by Mode of Transportation
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Service Type
12.2.8.2. Market Revenue and Forecast, by Product Type
12.2.8.3. Market Revenue and Forecast, by Mode of Transportation
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Service Type
12.3.2. Market Revenue and Forecast, by Product Type
12.3.3. Market Revenue and Forecast, by Mode of Transportation
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Service Type
12.3.5.2. Market Revenue and Forecast, by Product Type
12.3.5.3. Market Revenue and Forecast, by Mode of Transportation
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Service Type
12.3.6.2. Market Revenue and Forecast, by Product Type
12.3.6.3. Market Revenue and Forecast, by Mode of Transportation
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Service Type
12.3.7.2. Market Revenue and Forecast, by Product Type
12.3.7.3. Market Revenue and Forecast, by Mode of Transportation
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Service Type
12.3.8.2. Market Revenue and Forecast, by Product Type
12.3.8.3. Market Revenue and Forecast, by Mode of Transportation
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Service Type
12.4.2. Market Revenue and Forecast, by Product Type
12.4.3. Market Revenue and Forecast, by Mode of Transportation
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Service Type
12.4.5.2. Market Revenue and Forecast, by Product Type
12.4.5.3. Market Revenue and Forecast, by Mode of Transportation
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Service Type
12.4.6.2. Market Revenue and Forecast, by Product Type
12.4.6.3. Market Revenue and Forecast, by Mode of Transportation
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Service Type
12.4.7.2. Market Revenue and Forecast, by Product Type
12.4.7.3. Market Revenue and Forecast, by Mode of Transportation
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Service Type
12.4.8.2. Market Revenue and Forecast, by Product Type
12.4.8.3. Market Revenue and Forecast, by Mode of Transportation
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Service Type
12.5.2. Market Revenue and Forecast, by Product Type
12.5.3. Market Revenue and Forecast, by Mode of Transportation
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Service Type
12.5.5.2. Market Revenue and Forecast, by Product Type
12.5.5.3. Market Revenue and Forecast, by Mode of Transportation
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Service Type
12.5.6.2. Market Revenue and Forecast, by Product Type
12.5.6.3. Market Revenue and Forecast, by Mode of Transportation
12.5.6.4. Market Revenue and Forecast, by End User
13.1. Agility Logistics
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. AmerisourceBergen Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. DB Schenker
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. DHL International GmbH
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. FedEx Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Kerry Logistics Network Limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Kuehne + Nagel International AG
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. McKesson Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. SF Express Co. Ltd.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. United Parcel Service of America, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description